What is AstraZeneca's price targets for the next year?
Their forecasts range from $69.00 to $175.00. On average, they expect AstraZeneca's stock price to reach $122.00 in the next year. This suggests a possible upside of 108.1% from the stock's current price. View analysts' price targets for AstraZeneca or view top-rated stocks among Wall Street analysts.
What is the upside for AstraZeneca's stock?
Their forecasts range from $54.00 to $73.00. On average, they anticipate AstraZeneca's share price to reach $63.50 in the next twelve months. This suggests a possible upside of 9.4% from the stock's current price. View analysts' price targets for AstraZeneca or view top-rated stocks among Wall Street analysts.
Who owns AstraZeneca stock?
AstraZeneca's stock is owned by a variety of institutional and retail investors. Top institutional investors include Primecap Management Co. CA (1.51%), Fisher Asset Management LLC (0.65%), Bank of America Corp DE (0.34%), CIBC Private Wealth Group LLC (0.26%), Renaissance Technologies LLC (0.19%) and Dimensional Fund Advisors LP (0.10%).
When is AstraZeneca's next quarterly earnings announcement?
AstraZeneca is scheduled to release its next quarterly earnings announcement on Friday, April 29th 2022. View our earnings forecast for AstraZeneca. How were AstraZeneca's earnings last quarter? AstraZeneca PLC (NASDAQ:AZN) issued its earnings results on Wednesday, February, 9th.
See more
Is AstraZeneca stock a buy now?
Is AstraZeneca Stock A Buy Now? No, AstraZeneca stock isn't a buy in September 2021.
Is AstraZeneca traded in US?
In the US, AstraZeneca's Ordinary Shares are traded in the form of American Depositary Shares (ADSs), evidenced by American Depositary Receipts (ADRs), which are traded on Nasdaq under ticker symbol AZN.
What is the target price for AstraZeneca?
Stock Price Target AZNHigh$93.89Median$72.16Low$57.73Average$71.91Current Price$65.25
Why is AZN stock up?
2021 – A Fruitful Year for AstraZeneca In Emerging Markets, sales in countries outside China rose 89% in 2021 due to increased contribution from the COVID-19 vaccine, Vaxzevria. Excluding COVID-19 vaccine sales, Emerging Markets sales rose 10% despite the pricing headwinds in China.
How can I buy AstraZeneca stock?
How to buy shares in AstraZeneca PLC ADRCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
How can I invest in Zeneca Astra?
Investing in AstraZeneca sharesCreate or log in to your share dealing account.Search for 'AstraZeneca'Decide whether you want to trade at quote or on exchange.Choose the number of shares you want to buy.Confirm your purchase and monitor your investment.
Will AZN go up?
AstraZeneca PLC (NASDAQ:AZN) The 23 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 72.16, with a high estimate of 93.89 and a low estimate of 57.73. The median estimate represents a +10.57% increase from the last price of 65.26.
Is AZN a good stock?
The financial health and growth prospects of AZN, demonstrate its potential to outperform the market. It currently has a Growth Score of A. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.
How often does AZN Pay dividend?
Dividend Summary There are typically 2 dividends per year (excluding specials), and the dividend cover is approximately 1.3.
Who owns AstraZeneca shares?
The company is a wholly owned subsidiary of AstraZeneca plc, a United Kingdom-based pharmaceutical company.
Is AZN an ADR?
AstraZeneca has a level 2 ADR programme which is listed on Nasdaq under the symbol AZN. The ADR ratio is 1:2, meaning each ordinary share is represented by 2 ADRs.
How has AstraZeneca's stock price performed in 2022?
AstraZeneca's stock was trading at $57.2401 at the start of the year. Since then, AZN stock has increased by 7.9% and is now trading at $61.79. Vi...
How were AstraZeneca's earnings last quarter?
AstraZeneca PLC (NYSE:AZN) issued its quarterly earnings data on Friday, April, 29th. The company reported $0.95 EPS for the quarter, topping the c...
Is AstraZeneca a good dividend stock?
AstraZeneca(NYSE:AZN) pays an annual dividend of $1.93 per share and currently has a dividend yield of 3.08%.
Who are AstraZeneca's key executives?
AstraZeneca's management team includes the following people: Mr. Pascal Soriot D.V.M. , M.B.A., CEO & Exec. Director (Age 63, Pay $5.82M) Dr. Ar...
Who are some of AstraZeneca's key competitors?
Some companies that are related to AstraZeneca include Sanofi (SNY) , Kadmon (KDMN) , Solaris Resources (SLS) , Solaris Resources (SLS) , Sino...
What other stocks do shareholders of AstraZeneca own?
Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include Pfizer (PFE) , Johnson...
What is AstraZeneca's stock symbol?
AstraZeneca trades on the New York Stock Exchange (NYSE) under the ticker symbol "AZN."
How do I buy shares of AstraZeneca?
Shares of AZN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull...
What is AstraZeneca's stock price today?
One share of AZN stock can currently be purchased for approximately $61.79.
Should I buy or sell AstraZeneca stock right now?
12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 3 hol...
What is AstraZeneca's stock price forecast for 2022?
12 equities research analysts have issued twelve-month target prices for AstraZeneca's stock. Their forecasts range from $54.00 to $12,000.00. On a...
How has AstraZeneca's stock price performed in 2022?
AstraZeneca's stock was trading at $58.25 at the beginning of 2022. Since then, AZN shares have increased by 6.1% and is now trading at $61.79. Vi...
Are investors shorting AstraZeneca?
AstraZeneca saw a decrease in short interest in May. As of May 31st, there was short interest totaling 10,840,000 shares, a decrease of 34.0% from...
When is AstraZeneca's next earnings date?
AstraZeneca is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for AstraZen...
How were AstraZeneca's earnings last quarter?
AstraZeneca PLC (NASDAQ:AZN) posted its earnings results on Friday, April, 29th. The company reported $0.95 earnings per share (EPS) for the quarte...
How often does AstraZeneca pay dividends? What is the dividend yield for AstraZeneca?
AstraZeneca announced a semi-annual dividend on Friday, February 11th. Shareholders of record on Friday, February 25th will be given a dividend of...
Is AstraZeneca a good dividend stock?
AstraZeneca(NASDAQ:AZN) pays an annual dividend of $1.93 per share and currently has a dividend yield of 3.12%. View AstraZeneca's dividend history .
When did AstraZeneca's stock split? How did AstraZeneca's stock split work?
Shares of AstraZeneca split on Monday, July 27th 2015. The 2-1 split was announced on Friday, June 26th 2015. The newly created shares were payable...
When did AstraZeneca announce its earnings?
When is AstraZeneca's dividend?
AstraZeneca PLC (NASDAQ:AZN) announced its quarterly earnings data on Thursday, April, 29th. The company reported $0.82 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.71 by $0.11.
What is the dividend yield of AstraZeneca?
AstraZeneca announced a semi-annual dividend on Friday, February 12th. Stockholders of record on Friday, February 26th will be paid a dividend of $0.95 per share on Monday, March 29th. This represents a dividend yield of 2.7%. The ex-dividend date is Thursday, February 25th.
When did AstraZeneca change its name?
AstraZeneca pays an annual dividend of $1.86 per share and currently has a dividend yield of 3.07%. The dividend payout ratio of AstraZeneca is 92.54%. Payout ratios above 75% are not desirable because they may not be sustainable.
What is AstraZeneca's specialty?
The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Read More.
Nasdaq Global Select
AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. The company's marketed products include Tagrisso, Lynparza, Imfinzi, Enhertu, Koselugo, Lumoxiti, Equidacent, Zoladex, Faslodex, Iressa, Arimidex, Casodex/Cosudex, and others for oncology diseases; Onglyza, Bydureon, Lokelma, Byetta, Qtern, Symlin, and others for cardiovascular, renal, and metabolism diseases; and Symbicort, Pulmicort, Fasenra, Daliresp/Daxas, Duaklir, Tudorza/Eklira, Bevespi, Breztri, Anifrolumab, and others for respiratory and immunology diseases. It also offers other medicines and COVID-19 products, including Synagis, Fluenz Tetra/FluMist Quadrivalent, Seroquel IR/Seroquel XR, Vimovo, Movantik/Moventig, Nexium, Losec/Prilosec, and COVID-19 Vaccine AstraZeneca. The company serves primary care and specialty care physicians through distributors and local representative offices. It has a collaboration agreement with Daiichi Sankyo to develop and commercialize DS-1062 for the treatment of trophoblast cell-surface antigen 2 (TROP2) tumor; AliveCor, Inc. to develop non-invasive potassium monitoring solutions; Massachusetts General Hospital to accelerate digital health solutions; Sanguina on smartphone application study for hemoglobin management in patients with anemia of chronic kidney disease; Alchemab to enhance prostate cancer research; and Proteros biostructures GmbH to discover and develop novel small molecules for the treatment of various types of cancer. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Environmental, Social, and Governance Rating
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
Is AstraZeneca still in contract with European Union?
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.
Did AstraZeneca respond to the European Commission?
AstraZeneca has yet to react to a letter sent by the European Commission to complain over below-contract supplies of COVID-19 vaccines, Italian daily Corriere della Sera said, adding the Anglo-Swedish group missed a deadline indicated by Brussels. The European Union member states and the pharmaceutical company are at odds over the delivery of the shots after the group shipped to the block less than indicated in the initial agreement. "AstraZeneca has breached and continues to breach its contractual obligations on the production and supply of the initial 300 million doses for Europe," EU Head of Health and Food Safety DG Sandra Gallina said in a letter sent to the company on March 19, according to Corriere.
